WILMINGTON – Incyte Corp. announced Monday that it has signed a collaboration and license agreement valued at up to $117.5 million with InnoCare, a Chinese biopharmaceutical company. The deal gives […]
© 2024 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.